Substrate ablation as concomitant treatment in left atrial macroreentrant atrial tachycardia.
INV. INDEP SANITARY PRODUCT CLINIC.
Clinical trial information
- Promoter: RODRIGUEZ
- Execution start: 29/06/2021
- End of execution: 15/03/2025
- IP: MIGUEL ALVAREZ LOPEZ